header-logo header-logo

The final chance

31 March 2017 / David Locke
Issue: 7740 / Categories: Features
printer mail-detail
nlj_7740_locke

The law should not underestimate the desire of terminally ill patients to make a final & important contribution to medical advancement, says David Locke​

  • Why should a properly informed patient not be able to exercise their autonomy to elect for novel medical treatment

There are clearly many occasions when being first is an advantage, but just occasionally it is rather less obviously a benefit. One cannot, for example, easily conceive of how it might feel to be the first person put under anaesthetic to undergo a new experimental surgical procedure. It must be times like that when the benefits of evidence based medicine come into a very stark and individual perspective. After all, isn’t that what evidence-based medicine is when reduced to the personal level: the idea that enough people have already had it done to them so that you can be reasonably sure what the outcome is likely to be for you ?

Nonetheless, someone always has to be first and for every patient who undergoes a new treatment there must be a

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Hugh James—Phil Edwards

Hugh James—Phil Edwards

Serious injury teambolstered by high-profile partner hire

Freeths—Melanie Stancliffe

Freeths—Melanie Stancliffe

Firm strengthens employment team with partner hire

DAC Beachcroft—Tim Barr

DAC Beachcroft—Tim Barr

Lawyers’ liability practice strengthened with partner appointment in London

NEWS
Ceri Morgan, knowledge counsel at Herbert Smith Freehills Kramer LLP, analyses the Supreme Court’s landmark decision in Johnson v FirstRand Bank Ltd, which reshapes the law of fiduciary relationships and common law bribery
The boundaries of media access in family law are scrutinised by Nicholas Dobson in NLJ this week
Reflecting on personal experience, Professor Graham Zellick KC, Senior Master of the Bench and former Reader of the Middle Temple, questions the unchecked power of parliamentary privilege
Geoff Dover, managing director at Heirloom Fair Legal, sets out a blueprint for ethical litigation funding in the wake of high-profile law firm collapses
James Grice, head of innovation and AI at Lawfront, explores how artificial intelligence is transforming the legal sector
back-to-top-scroll